Nutex Health Inc.

NUTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$202.78

+$1.30 (+0.65%)

Sep 22, 2026, 1:11 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.39B

Enterprise Value $1.5B

Beta 2.02

Average Volume 147.44K

Shares Outstanding (Diluted) N/A

Shares Change YoY 22.63%

Institutional Ownership 41.88%

Exchange NASDAQ

ISIN US67079U3068

Price Performance

Price Change 1M 7.8%

Price Change 3M 36.9%

Price Change 6M 100.7%

Price Change YTD 36.0%

Price Change 1Y 102.1%

Price Change 3Y 575.6%

Price Change 5Y -85.1%

1M CAGR (ann.) 24.3%

1Y CAGR (ann.) 116.7%

5Y CAGR (ann.) -14.8%

All-Time CAGR 7.6%

Valuation

PE Ratio 7.97

Forward PE 7.34

PEG Ratio 0.04

Forward PEG 27.37

PS Ratio 1.64

Forward PS 1.40

PB Ratio 2.73

P/FCF Ratio 3.98

P/Adj. FCF Ratio 4.04

P/OCF Ratio 4.95

EV/Sales 1.77

EV/EBIT 6.20

EV/EBITDA 4.23

EV/FCF 4.30

Earnings Yield 12.6%

FCF Yield 25.1%

Adj. FCF Yield 24.7%

Financial Health

Net Debt $110.93M

Total Debt $316.13M

Cash & Short-Term Investments $205.21M

Total Assets $964.63M

Current Ratio 5.00

Quick Ratio 4.96

Debt / Equity Ratio 0.88

Debt / EBITDA 0.89

Debt / FCF 0.91

OCF / Debt 1.12

Interest Coverage 18.42

Altman Z-Score 3.85

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 51.3%

Operating Profit Margin 43.0%

EBITDA Margin 45.4%

Net Profit Margin 21.3%

FCF Margin 41.2%

Adj. FCF Margin 40.5%

SBC / Revenue 1.4%

SBC Impact (per share) -1.6%

Returns

Return on Assets 18.6%

Return on Equity 51.9%

Return on Invested Capital 33.4%

Return on Capital Employed 43.0%

Return on Tangible Assets 19.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 62.5%

Revenue CAGR 5Y 37.6%

Revenue CAGR 10Y 87.3%

EPS CAGR 3Y 202.5%

EPS CAGR 5Y 11.7%

EPS CAGR 10Y 91.6%

FCF CAGR 3Y 113.1%

FCF CAGR 5Y 36.8%

FCF CAGR 10Y 136.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 16, 2026

EPS Estimate (next Q) $5.71

EPS Growth Est (next Q) -26.4%

Revenue Est (next Q) $214.98M

Revenue Growth Est (next Q) -19.7%

Fair Value Estimates

Graham Number $204.94

Graham Upside 1.7%

Lynch Fair Value $294.51

Lynch Upside 46.2%

Price Target $310

Price Target Upside 53.9%

Cash Flow

Operating Cash Flow $355.14M

Free Cash Flow $348.49M

Adj. Free Cash Flow $342.82M

FCF Per Share $39.90

OCF Per Share $40.70

OCF/S Ratio 33.0%

Income Statement

Revenue $846.72M

Gross Profit $434.03M

Operating Income $364.27M

EBITDA $353.83M

Net Income $179.92M

EPS (Diluted) $25.28

Revenue / Employee $816.51K

Profit / Employee $173.5K

Employees 1,037